VYGR

Voyager Therapeutics (VYGR)

About Voyager Therapeutics (VYGR)

Voyager Therapeutics, Inc. is a clinical-stage gene therapy company, which engages in the development of treatments for severe neurological diseases. Its pipeline of gene therapy programs includes VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01. The company was founded by Guang Ping Gao, Mark A. Kay, Krystof Bankiewicz, and Phillip Zamore in June 2013 and is headquartered in Lexington, MA.

Details

Daily high

$3.92

Daily low

$3.78

Price at open

$3.82

52 Week High

$10.66

52 Week Low

$3.56

Market cap

214.2M

Dividend yield

0.00%

Volume

428,036

Avg. volume

355,553

P/E ratio

5.38

Voyager Therapeutics News